Infographic: Ranibizumab for macular oedema following branch retinal vein occlusion (BRAVO)

Eye (Lond). 2024 Aug;38(Suppl 2):61-62. doi: 10.1038/s41433-024-03122-0. Epub 2024 May 22.
No abstract available

MeSH terms

  • Angiogenesis Inhibitors* / therapeutic use
  • Humans
  • Intravitreal Injections*
  • Macular Edema* / drug therapy
  • Macular Edema* / etiology
  • Ranibizumab* / administration & dosage
  • Ranibizumab* / therapeutic use
  • Retinal Vein Occlusion* / complications
  • Retinal Vein Occlusion* / drug therapy
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Visual Acuity

Substances

  • Ranibizumab
  • Angiogenesis Inhibitors
  • Vascular Endothelial Growth Factor A